|

Peanuts for Cardiometabolic, Brain, and Intestinal Health

RECRUITINGN/ASponsored by Georgia State University
Actively Recruiting
PhaseN/A
SponsorGeorgia State University
Started2025-03
Est. completion2027-09
Eligibility
Age20 Years – 59 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06867198

Summary

The overall objective of this 13-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.

Eligibility

Age: 20 Years – 59 YearsHealthy volunteers accepted
Inclusion Criteria:

* men and women
* 20-59 years of age
* Prediabetes (fasting blood glucose levels 100-125 mg/dL and/or HbA1c between 5.7-6.4%)

Exclusion Criteria:

* Allergies to peanuts and peanut products
* Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
* Active cancer, gastrointestinal, renal, cardiovascular, thyroid, and neurological diseases or severe head injury
* Smoking
* Consumes greater than 2 alcoholic beverages per day
* Consumes antioxidant, probiotic, and prebiotic supplements
* Pregnant or Lactating
* Actively participating in a weight loss program

Conditions9

AdultArterial Stiffness, Blood PressureCognitionDiabetesEndothelial Function (Reactive Hyperemia)Gut MicrobiotaMicrovascular FunctionPreDiabetesPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)

Locations1 site

Georgia State University
Atlanta, Georgia, 30303
Rafaela G Feresin, PhD404-413-1233peanuts@gsu.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.